Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states

Clinical Immunology

Volumn 134, Issue 2, 2010, Pages 206-216

  Macaubas, Claudia ^a   Nguyen, Khoa ^a   Deshpande, Chetan ^a   Phillips, Carolyn ^a   Peck, Ariana ^a   Lee, Tzielan ^b   Park, Jane L ^a,b   Sandborg, Christy ^b   Mellins, Elizabeth D ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Inflammation; Innate immunity; Juvenile arthritis; Monocytes

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL COUNT; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNE DYSREGULATION; IMMUNOPHENOTYPING; INFLAMMATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYARTHRITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; B-LYMPHOCYTES; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MONOCYTES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 73449117152     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.09.010     Document Type: Article

References (78)

1. Bowyer S.L., Roettcher P.A., Higgins G.C., Adams B., Myers L.K., Wallace C., Rennebohm R., Moore T.L., Pepmueller P.H., Spencer C., Wagner-Weiner L., Rabinovich E., Passo M., Lovell D.J., Madson K., McCurdy D., Zemel L., Schikler K.N., Szer I., Kurtin P., and Lindsley C. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J. Rheumatol. 30 (2003) 394-400
2. Adib N., Silman A., and Thomson W. Outcome following onset of juvenile idiopathic inflammatory arthritis: I. Frequency of different outcomes. Rheumatology 44 (2005) 995-1001
3. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., He X., Maldonado-Coco J., Orozco-Alcada J., Prieur A.M., Suarez-Almazor M.E., Woo P., and I.L.o.A.f. Rheumatology, International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001. J. Rheumatol. 31 (2004) 390-392
4. Borchers A.T., Selmi C., Cheema G., Keen C.L., Shoenfeld Y., and Gershwin M.E. Juvenile idiopathic arthritis. Autoimmun. Rev. 5 (2006) 279-298
5. Macaubas C., Nguyen K., Milojevic D., Park J.L., and Mellins E.D. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat. Rev. Rheumatology (2009) 5
6. Schaller J.G. Juvenile rheumatoid arthritis. Pediatr. Rev. 18 (1997) 337-349
7. Prahalad S., and Glass D.N. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 6 (2008) 11
8. Walker S.M., Shaham B., McCrudy D.K., Wietting H., Arora Y.K., Hanson V., and Bernstein B. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J. Rheumatol. 17 (1990) 936-940
9. Oen K., Malleson P., Cabral D., Rosenberg A., Petty R., Reed M., Schroeder M., and Cheang M. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J. Rheumatol. 30 (2003) 585-593
10. Ramanan A.V., and Grom A.A. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?. Rheumatology 44 (2005) 1350-1353
11. Efthimiou P., and Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin. Arthritis Rheum. 36 (2006) 144-152
12. Quartier P., Taupin P., Bourdeaut F., Lemelle I., Pillet P., Bost M., Sibilia J., Koné-Paut I., Gandon-Laloum S., LeBideau M., Bader-Meunier B., Mouy R., Debré M., Landais P., and Prier A.M. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum. 48 (2003) 1093-1101
13. Reiff A. The use of anakinra in juvenile arthritis. Curr. Rheumatol. Rep. 7 (2005) 434-440
14. Lequerre T., Quartier P., Rosellini D., Alaoui F., De Bandt M., Mejjad O., Kone-Paut I., Michel M., Dernis E., Khellaf M., Limal N., Job-Deslandre C., Fautrel B., Le Loet X., and Sibilia J. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann. Rheum. Dis. 67 (2008) 302-308
15. de Benedetti F., Massa M., Robbioni P., Ravelli A., Burgio G.R., and Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Reum. 34 (1991) 1158-1163
16. Ogilvie E.M., Khan A., Hubank M., Kellam P., and Woo P. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum. 56 (2007) 1954-1965
17. Woo P., Wilkinson N., Prieur A.M., Southwood T., Leone V., Livermore P., Wythe H., Thomson D., and Kishimoto T. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res. Ther. 7 (2005) R1281-R1288
18. Yokota S., Miyamae T., Imagawa T., Iwata N., Katakura S., mori M., Woo P., Nishimoto N., Yoshizaki K., and Kishimoto T. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 52 (2005) 818-825
19. Wouters C.H., Ceuppens J.L., and Stevens E.A. Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 20 (2002) 239-248
20. Tsokos G.C., Mavridis A., Inghirami G., Pillemer S.R., Emery H.M., and Magilavy D.B. Cellular immunity in patients with systemic juvenile rheumatoid arthritis. Clin. Immunol. Immunopathol. 42 (1987) 86-92
21. Martini A., Massa M., De Benedetti F., Viola S., Neirotti G., and Burgio R.G. CD5 positive B lymphocytes in seronegative juvenile arthritis. J. Rheumatol. 17 (1990) 932-935
22. Fall N., Barnes M., T.S., Luyrink L., Olson J., Ilowite N.T., Gottlieb B.S., Griffin T., Sherry D.D., Thompson S., Glass D.N., Colbert R.A., and Grom A.A. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Reum. 56 (2007) 3793-3804
23. Yabuhara A., Yang F.C., Nakazawa T., Iwasaki Y., Mori T., Koike K., Kawai H., and Komiyama A. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J. Rheumatol. 23 (1996) 171-177
24. Grom A.A., Villanueva J., Lee S., Goldmuntz E.A., Passo M.H., and Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J. Pediatr. 142 (2003) 292-296
25. Villanueva J., Lee S., Giannini E.H., Graham T.B., Passo M.H., Filipovich A., and Grom A.A. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res. Ther. 7 (2005) R30-37
26. Hazen M.M., Woodward A.L., Hofmann I., Degar B.A., Grom A., Filipovich A.H., and Binstadt B.A. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum. 58 (2008) 567-570
27. Sandborg C.I., Nepom B.S., and Mellins E. Juvenile Arthritis. In: Rich T.F.R., Kotzin B., and Shearer W. (Eds). Clinical Immunology (2001), Harcourt Health Sciences, London
28. Sandborg C., Holmes T.H., Lee T., Biederman K., Bloch D.A., Emery H., McCurdy D., and Mellins E.D. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J. Rheumatol. 33 (2006) 2322-2329
29. Passlick B., Flieger D., and Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74 (1989) 2527-2534
30. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells. J. Exp. Med. 203 (2006) 1701-1711
31. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., and Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203 (2006) 1693-1700
32. Seddiki N., Santner-Nanan B., Tangye S.G., Alexander S.I., Solomon M., Lee S., Nanan R., and Fazekas de St Groth B. Persistence of naive CD45RA+regulatory T cells in adult life. Blood 107 (2006) 2830-2838
33. MacDonald K.P.A., Munster D.J., Clark G.J., Dzionek A., Schmitz J., and Hart D.N.J. Characterization of human blood dendritic cell subsets. Blood 100 (2002) 4512-4520
34. Drohan L., Harding J.J., Holm B., Cordoba-Tongson E., Dekker C.L., Holmes T., Maecker H., and Mellins E.D. Selective developmental defects of cord blood antigen-presenting cell subsets. Hum. Immunol 65 (2004) 1356-1369
35. Grage-Griebenow E., Flad H.D., and E.M. Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69 (2001) 11-20
36. Ravetch J.V., and Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19 (2001) 275-290
37. Akashi-Takamura S., and Miyake K. TLR accessory molecules. Curr. Opin. Immunol. 20 (2008) 420-425
38. Steinman R. Linking innate to adaptive immunity through dendritic cells. Novartis Found. Symp. 279 (2006) 101-109 discussion 109
39. Piccioli D., Tavarini S., Borgogni E., Steri V., Nuti S., Sammicheli C., Bardelli M., Montagna D., Locatelli F., and Wack A. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 109 (2007) 5371-5379
40. Farag S.S., and Caligiuri M.A. Human natural killer cell development and biology. Blood Rev. 20 (2005) 123-137
41. Nakata M., Smyth M.J., Norihisa Y., Kawasaki A., Shinkai Y., Okumura K., and Yagita H. Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo. J. Exp. Med. 172 (1990) 1877-1880
42. Koizumi H., Liu C.C., Zheng L.M., Joag S.V., Bayne N.K., Holoshitz J., and Young J.D. Expression of perforin and serine esterases by human gamma/delta T cells. J. Exp. Med. 173 (1991) 499-502
43. Beetz S., Wesch D., Marischen L., Welte S., Oberg H.H., and Kabelitz D. Innate immune functions of human gammadelta T cells. Immunobiology 213 (2008) 173-182
44. Milojevic D., Nguyen K.D., Wara D., and Mellins E.D. Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr. Rheumatol. Online J. 6 (2008) 20
45. Roord S.T., de Jager W., Boon L., Wulffraat N., Martens A., Prakken B., and van Wijk F. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+regulatory T cells. Blood 111 (2008) 4838-4839
46. Linsen L., Somers V., and Stinissen P. Immunoregulation of autoimmunity by natural killer T cells. Hum. Immunol. 66 (2005) 1193-1202
47. Smolewska E., Brozik H., Smolewski P., Biernacka-Zielinska M., Darzynkiewicz Z., and Stanczyk J. Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis. Ann. Rheum. Dis. 62 (2003) 761-763
48. Olsen N., Sokka T., Seehorn C.L., Kraft B., Maas K., Moore J., and Aune T.M. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann. Rheum. Dis. 63 (2004) 1387-1392
49. Batliwalla F.M., Baechler E.C., Xiao X., Li W., Balasubramanian S., Khalili H., Damle A., Ortmann W.A., Perrone A., Kantor A.B., Gulko P.S., Kern M., Furie R., Behrens T.W., and Gregersen P.K. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 6 (2005) 388-397
50. Jarvis J.N., Dozmorov I., Jiang K., Frank M.B., Szodoray P., Alex P., and Centola M. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res. Ther. 6 (2004) R15-R32
51. Barnes M.G., Aronow B.J., Luyrink L.K., Moroldo M.B., Pavlidis P., Passo M.H., Grom A.A., Hirsch R., Giannini E.H., Colbert R.A., Glass D.N., and Thompson S.D. Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+chemokine genes relate to course of arthritis. Rheumatology 43 (2004) 973-979
52. Pascual V., Allantaz F., Arce E., Punaro M., and Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201 (2005) 1479-1486
53. Furukawa S., Ichiyama T., and Matsubara T. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin. Exp. Immunol. 141 (2005) 381-387
54. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., and Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR+ monocytes are a major source of TNF. J. Immunol. 168 (2002) 3536-3542
55. Ziegler-Heitbrock H.W., Fingerle G., Strobel M., Schraut W., Stelter F., Schutt C., Passlick B., and Pforte A. The novel subset of CD14+/CD16+blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23 (1993) 2053-2058
56. Guan G., Kramer S.F., and Kramer P.R. 17 Beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 50 (2004) 1967-1975
57. Fernandez G., Ramos M., Gomez S., Dran G., Exeni R., Alduncin M., Grimoldi I., Vallejo G., Elias-Costa C., Isturiz M., and Palermo M. Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J. Leukoc. Biol. 78 (2005) 853-861
58. Soares G., Barral A., Costa J., Barral-Netto M., and Van Weyenbergh J. CD16+monocytes in human cutaneous leishmaniasis: increased ex vivo levels and correlation with clinical data. J. Leukoc. Biol. 79 (2006) 36-39
59. Oen K., Fast M., and Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence. J. Rheumatol. 22 (1995) 745-750
60. Lindsley C.B. Seasonal variation in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum. 30 (1987) 838-839
61. Uziel Y., Pomeranz A., Brik R., Navon P., Mukamel M., Press J., Barash J., Tauber T., Harel L., Virgilis D., Bibi H., Heldenberg D., and Wolach B. Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. J. Rheumatol. 26 (1999) 1187-1189
62. Heidenreich S. Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J. Leukoc. Biol. 65 (1999) 737-743
63. de Benedetti F., Massa M., Robbioni P., Ravelli A., Burgio G.R., and Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 34 (1991) 1158-1163
64. Behrens E.M., Beukelman T., Paessler M., and Cron R.Q. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J. Rheumatol. 34 (2007) 1133-1138
65. Frosch M., Metze D., Foell D., Vogl T., Sorg C., Sunderkotter C., and Roth J. Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. Exp. Dermatol. 14 (2005) 259-265
66. Blanco P., Palucka A.K., Pascual V., and Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 19 (2008) 41-52
67. Smolewska E., Stanczyk J., Brozik H., Biernacka-Zielinska M., Cebula B., Robak T., and Smolewski P. Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis. Ann. Rheum. Dis. 67 (2008) 762-768
68. Shodell M., Shah K., and Siegal F.P. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus 12 (2003) 222-230
69. Rozkova D., Horvath R., Bartunkova J., and Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120 (2006) 260-271
70. Wulffraat N.M., Rijkers G.T., Elst E., Brooimans R., and Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology 42 (2003) 375-379
71. Hoshino T., Ohta A., Nakao M., Ota T., Inokuchi T., Matsueda S., Gouhara R., Yamada A., Itoh K., and Oizumi K. TCR gamma delta+ T cells in peripheral blood of patients with adult Still's disease. J. Rheumatol. 23 (1996) 124-129
72. Black A.P.B., Bhayani H., Ryder C.A.J., Pugh M.T., Gardner-Medwin J.M.M., and Southwood T.R. An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis. Arthritis Res. Ther. 5 (2003) R277-284
73. Chen D.Y., Hsieh T.Y., Hsieh C.W., Lin F.J., and Lan J.L. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease. Arthritis Rheum. 57 (2007) 1530-1538
74. Jelusic M., Lukic I.K., Tambic-Bukovac L., Dubravcic K., Malcic I., Rudan I., and Batinic D. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis. Clin. Rheumatol. 26 (2007) 1332-1334
75. Murray K.J., Luyrink L., Grom A.A., Passo M.H., Emery H., Witte D., and Glass D.N. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J. Rheumatol. 23 (1996) 2116-2124
76. Masters S., Simon A., Aksentijevich I., and Kastner D. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu. Rev. Immunol. 27 (2009) 621-668
77. Tighe P., Powell R., Ghaemmaghami A., Ziegler-Heitbrock L., Radford P., and Todd I. Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 56 (2007) 4182-4188
78. Ravelli A., and Martini A. Juvenile idiopathic arthritis. Lancet 369 (2007) 767-778